Suppr超能文献

马来西亚扩大新生儿筛查的现状与未来关注点:可持续性、挑战与展望

Present status and future concerns of expanded newborn screening in malaysia: sustainability, challenges and perspectives.

作者信息

Leong Yin Hui, Gan Chee Yuen, Tan Mohd Adi Firdaus, Majid Mohamed Isa Abdul

机构信息

Centre for Advanced Analytical Toxicology Services, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia.

出版信息

Malays J Med Sci. 2014 Mar;21(2):63-7.

Abstract

Newborn screening (NBS) program is an important tool for the early diagnosis and preventive treatment of life-long impairments. NBS is one of the strategies recommended by the World Health Organization to promote the primary prevention of congenital anomalies and the health of children with these conditions. However, NBS initiation and implementation in developing countries, especially South-East Asian and North African regions, are slow and challenging. Expanded NBS is not mandatory and has not yet been incorporated into the public healthcare system in our country. Limited funding, manpower shortages, inadequate support services, low public awareness, and uncertain commitment from healthcare practitioners are the main challenges in establishing this program at the national level. Involvement and support from policy makers are very important to the success of the program and the benefit of the entire population.

摘要

新生儿筛查(NBS)项目是早期诊断和预防终身性损伤的重要工具。NBS是世界卫生组织推荐的促进先天性异常一级预防及患有这些病症儿童健康的策略之一。然而,发展中国家,尤其是东南亚和北非地区,NBS的启动和实施进展缓慢且面临挑战。扩大后的NBS并非强制性的,在我国尚未纳入公共医疗体系。资金有限、人力短缺、支持服务不足、公众意识淡薄以及医疗从业者的承诺不确定是在国家层面建立该项目的主要挑战。政策制定者的参与和支持对于项目的成功及全体民众的受益至关重要。

相似文献

3
Benefits and challenges of newborn hearing screening for developing countries.发展中国家新生儿听力筛查的益处与挑战。
Int J Pediatr Otorhinolaryngol. 2004 Mar;68(3):287-305. doi: 10.1016/j.ijporl.2003.10.015.
5
Newborn screening in the developing countries.发展中国家的新生儿筛查。
Curr Opin Pediatr. 2018 Dec;30(6):734-739. doi: 10.1097/MOP.0000000000000683.
7
Current Status of Newborn Screening in Southeastern Europe.东南欧新生儿筛查的现状
Front Pediatr. 2021 May 7;9:648939. doi: 10.3389/fped.2021.648939. eCollection 2021.

引用本文的文献

6
Rare disease in Malaysia: Challenges and solutions.马来西亚罕见病:挑战与解决方案。
PLoS One. 2020 Apr 2;15(4):e0230850. doi: 10.1371/journal.pone.0230850. eCollection 2020.
7
State of rare disease management in Southeast Asia.东南亚罕见病管理状况。
Orphanet J Rare Dis. 2016 Aug 2;11(1):107. doi: 10.1186/s13023-016-0460-9.

本文引用的文献

1
Cost-effectiveness of expanded newborn screening in Texas.德克萨斯州扩大新生儿筛查的成本效益分析。
Value Health. 2012 Jul-Aug;15(5):613-21. doi: 10.1016/j.jval.2012.02.007. Epub 2012 Jun 7.
6
Newborn screening in the Asia Pacific region.亚太地区的新生儿筛查。
J Inherit Metab Dis. 2007 Aug;30(4):490-506. doi: 10.1007/s10545-007-0687-7. Epub 2007 Jul 23.
9
U.S. newborn screening policy dilemmas for the twenty-first century.21世纪美国新生儿筛查政策困境
Mol Genet Metab. 2001 Sep-Oct;74(1-2):64-74. doi: 10.1006/mgme.2001.3238.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验